ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 80

Paresthesias in Fibromyalgia Patients

Robert S. Katz1, Lauren Kwan2, Kelli Davis2 and Jessica L. Polyak2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:  
Paresthesias are common in patients with fibromyalgia.  We evaluated the
symptoms of numbness and tingling in fibromyalgia patients and rheumatic
disease controls without fibromyalgia.

Methods:   104
fibromyalgia patients meeting the 2010 ACR criteria for fibromyalgia and 124
rheumatic disease controls without fibromyalgia answered a questionnaire
regarding the presence of paresthesias. They were asked if they had
numbness or tingling; whether it was constant, intermittent, or frequent; and
also the location of their numbness and tingling; the intensity; whether there
were color changes in the hands or feet; skin temperature changes; symptoms
related to rubbing the area; symptoms related to putting on socks or gloves;
and numbness and tingling related to activity.

Results: 104
fibromyalgia patients and 124 rheumatic disease controls without fibromyalgia
responded to the questionnaire during an office visit in a rheumatology
practice.  45% of the fibromyalgia patients compared with 19% of the
controls indicated that they had frequent paresthesias, 55% of fibromyalgia
patients versus 33% of the controls indicated that they had intermittent
paresthesias, and 20% of fibromyalgia patients versus 9% of controls answered
that they had constant paresthesias. 51% of the fibromyalgia patients
versus 41% of the controls experience color changes in the hands and feet, 61%
of fibromyalgia patients versus 45% of the controls had skin temperature
changes, 28%.

On a 1-10 visual analog scale
with 10 being very severe, fibromyalgia patients were 5.51 and controls were
4.83.

Conclusion:   Fibromyalgia patients more often experience paresthesias
than rheumatic disease controls.  The paresthesias are more commonly
frequent or constant compared with rheumatic disease controls without
fibromyalgia.  The paresthesias are often widespread and frequently
associated with color changes in the hands and feet, skin temperature changes,
symptoms when rubbing the area, symptoms with putting on socks or gloves, and
paresthesias related to activity.

The subjective sensations of
numbness and tingling, without a neurological deficit, appear to be a common
component of the fibromyalgia syndrome.  We suggest that
fibromyalgia-related paresthesias be further described, such as using a term
like “paresthesias of unknown etiology”or  Idiopathic paresthesias
(IP). 

Similar to other syndromes based
on subjective symptoms, such as irritable bowel syndrome and migraine, the
terms “paresthesias of unknown etiology” or “idiopathic paresthesias” may
describe patients with and without fibromyalgia who do not have a clear
neurological basis for these symptoms. 

A descriptive name might be reassuring
to patients who otherwise feel that the physician thinks they are “crazy,” or
that their paresthesias might be part of a more serious neurological syndrome
(such as multiple sclerosis), despite reassurance from a neurologist or other
practitioner.

 


Disclosure: R. S. Katz, None; L. Kwan, None; K. Davis, None; J. L. Polyak, None.

To cite this abstract in AMA style:

Katz RS, Kwan L, Davis K, Polyak JL. Paresthesias in Fibromyalgia Patients [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/paresthesias-in-fibromyalgia-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/paresthesias-in-fibromyalgia-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology